EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma

Ruiyang Xie, Bingqing Shang, Hongzhe Shi, Xingang Bi, Yan Song, Wang Qu, Hongsong Bai, Linjun Hu, Jie Wu iD, Honglei Cui, Gan Du, Lei Guo und 6 weitere

Cancer Medicine · 2023-12 · 12 (24) · 21807-21819

DOI: 10.1002/cam4.6748 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 28.11.2023. Verfasst von Ruiyang Xie und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Extracellular Traps. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Hope Run Special Fund of Cancer Foundation of China, Beijing Municipal Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The efficacy of systemic therapy regimens, such as immune checkpoint inhibitors and tyrosine kinase inhibitors (IO‐TKI) and targeted therapy, for metastatic clear cell renal cell carcinoma (ccRCC) remains unpredictable due to the lack of effective biomarkers. Neutrophil extracellular trap (NET) plays an important role in promoting ccRCC. This study explores the NET predictive value of the efficacy in metastatic ccRCC.

Methods

In this retrospective study, patients with metastatic ccRCC who received targeted drugs and IO‐TKI were included. Immunofluorescence staining was utilized to quantify the levels of tissue NETs through cell counts of H3Cit(+) and MPO(+) cells.

Results

A total of 183 patients with metastatic ccRCC were enrolled, including 150 patients who received TKIs and 33 patients who received IO‐TKI. The levels of NETs in tumor tissue were significantly higher than in para‐tumor tissue ( p < 0.001). In terms of predicting drug efficacy, a correlation between NET levels and progression‐free survival (PFS) was observed in the TKI with metachronous metastasis group (HR 1.73 [95% CI 1.02–2.91], log‐rank p = 0.037), while no correlation was observed in the TKI with synchronous metastasis group and IO‐TKI group. Regarding overall survival (OS), activated NET levels were associated with poor OS in both TKI (HR 1.60 [95% CI 1.05–2.43], log‐rank p = 0.017) and IO‐TKI group (HR 4.35 [95% CI 1.06–17.82], log‐rank p =0.047). IMDC score (HR 1.462 [95% CI 1.030–2.075], p = 0.033) and tumor tissue NET levels (HR 1.733 [95% CI 1.165–2.579], p = 0.007) were independent prognostic risk factors for OS in patients with metastatic ccRCC.NET level was associated with poor OS in both TKI (HR 1.60 [95% CI 1.05–2.43], log‐rank p = 0.017).

Conclusions

The active NET levels in tumor tissue can predict drug efficacy in patients with metastatic ccRCC who received systemic therapy. Elevated levels of NETs in tumor tissue were also associated with poor efficacy in OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsExtracellular TrapsHumansRetrospective StudiesPrognosisProtein Kinase Inhibitors

Stichwörter der Autor:innen

efficacy predictionmetastatic clear cell renal cell carcinomaneutrophil extracellular trapssystemic therapy

Substanzen

Protein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Urology, Peking University Third Hospital, Beijing, China.
  • Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Urology, Cancer Hospital of Huanxing, Beijing, China.
  • Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Jie Wu, Jianzhong Shou

Förderung

  • Beijing Hope Run Special Fund of Cancer Foundation of China
  • Beijing Municipal Natural Science Foundation
  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Xie, R., Shang, B., Shi, H., Bi, X., Song, Y., Qu, W., Bai, H., Hu, L., Wu, J., Cui, H., Du, G., Guo, L., Zheng, S., Ying, J., Li, C., Ma, J., Zhou, A., & Shou, J. (2023). Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma. Cancer Medicine, 12(24), 21807-21819. https://doi.org/10.1002/cam4.6748

Vancouver

Xie R, Shang B, Shi H, Bi X, Song Y, Qu W, et al. Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma. Cancer Medicine. 2023;12(24):21807-21819. doi:10.1002/cam4.6748

BibTeX
@article{Xie2023,
  author = {Xie, Ruiyang and Shang, Bingqing and Shi, Hongzhe and Bi, Xingang and Song, Yan and Qu, Wang and Bai, Hongsong and Hu, Linjun and Wu, Jie and Cui, Honglei and Du, Gan and Guo, Lei and Zheng, Shan and Ying, Jianming and Li, Changling and Ma, Jianhui and Zhou, Aiping and Shou, Jianzhong},
  title = {Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma},
  journal = {Cancer Medicine},
  year = {2023},
  volume = {12},
  number = {24},
  pages = {21807--21819},
  doi = {10.1002/cam4.6748}
}
Kostenlos starten →